A PHASE 2 CLINICAL TRIAL OF RITUXIMAB AND β‐GLUCAN PGG IN RELAPSED/REFRACTORY INDOLENT B‐CELL NON‐HODGKIN LYMPHOMA

Saved in:
Bibliographic Details
Published inHematological oncology Vol. 37; no. S2; pp. 521 - 523
Main Authors Jacobson, C.A., Redd, R., Reynolds, C., Fields, M., Armand, P., Fisher, D.C., Jacobsen, E.D., LaCasce, A.S., Bose, N., Ottoson, N., Freedman, A.
Format Journal Article
LanguageEnglish
Published Chichester Wiley Subscription Services, Inc 01.06.2019
Subjects
Clinical trials
Glucan
Immunotherapy
Lymphocytes B
Lymphoma
Monoclonal antibodies
Non-Hodgkin's lymphoma
Rituximab
Targeted cancer therapy
β-Glucan
Online AccessGet full text

Cover

More Information
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.207_2631